The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Unravelling early self-regulation: A longitudinal study. National data show persistent issues in Australian children's social-emotional vulnerability. Research shows we have had limited success shifting these trajectories through current education and intervention efforts. In short, we understand enough about self-regulation to establish it as a priority target in early childhood, yet not enough to meaningfully alter current trajectories. This project will develop a ‘big picture’ theory of child ....Unravelling early self-regulation: A longitudinal study. National data show persistent issues in Australian children's social-emotional vulnerability. Research shows we have had limited success shifting these trajectories through current education and intervention efforts. In short, we understand enough about self-regulation to establish it as a priority target in early childhood, yet not enough to meaningfully alter current trajectories. This project will develop a ‘big picture’ theory of children’s self-regulation abilities and change, supported by Australia’s first longitudinal study of early self-regulation, from preschool into early primary school (ages 4 to 6). This robust theory of change is expected to better position ongoing education and intervention efforts to succeed.Read moreRead less
Speaking my language: International speech acquisition in Australia. It is important to differentiate between children who have communication impairment (difficulty learning all languages) from those who only have difficulty learning subsequent language(s). Communication impairment in multilingual children is both undiagnosed and over-diagnosed due to lack of culturally-sensitive measurement tools. Early intervention can ameliorate communication impairment in children and can reduce subsequent e ....Speaking my language: International speech acquisition in Australia. It is important to differentiate between children who have communication impairment (difficulty learning all languages) from those who only have difficulty learning subsequent language(s). Communication impairment in multilingual children is both undiagnosed and over-diagnosed due to lack of culturally-sensitive measurement tools. Early intervention can ameliorate communication impairment in children and can reduce subsequent educational, social and occupational outcomes of untreated communication impairment. By working with people around the world, this Fellowship will result in the development of the International Speech Assessment designed to differentially identify children and to specify holistic early intervention goals.Read moreRead less
Investigating mobile technologies in young children's everyday worlds. This project will seek to understand how young children access benefits of learning/ play through mobile internet-connected technologies in homes, preschools and communities. It will provide empirical evidence of everyday practices to inform policy development about smart technology use in the early years to support early childhood educators and families.
mTOR signalling in serous ovarian cancer. Serous ovarian cancer is the most aggressive and lethal gynaecological cancer in Australian women. Activation of Mammalian Target of Rapamycin (mTOR) is frequently observed and associated with poor prognosis in ovarian cancer patients. However, the mechanisms dysregulating mTOR in the pathogenesis of ovarian cancer are unknown. In preliminary studies, deletion of genes regulating mTOR signalling in up to 60 per cent of human serous ovarian cancer patien ....mTOR signalling in serous ovarian cancer. Serous ovarian cancer is the most aggressive and lethal gynaecological cancer in Australian women. Activation of Mammalian Target of Rapamycin (mTOR) is frequently observed and associated with poor prognosis in ovarian cancer patients. However, the mechanisms dysregulating mTOR in the pathogenesis of ovarian cancer are unknown. In preliminary studies, deletion of genes regulating mTOR signalling in up to 60 per cent of human serous ovarian cancer patients was observed. This project will provide mechanistic details of involvement of mTOR signalling in pathogenesis of the serous ovarian carcinoma, and develop a rationale for targeting mTOR pathway in these patients. Read moreRead less
The critical role of the class III histone deacetylase SIRT2 in stabilizing N-Myc oncoprotein. Cancer is the commonest cause of death from disease in children. Neuroblastoma is the commonest solid tumor in early childhood. This project will investigate the critical roles of SIRT2 protein in increasing the expression of N-Myc oncoprotein and consequently inducing neuroblastoma, and SIRT2 inhibitors as anticancer agents.
Identification of novel therapeutic targets for selectively eliminating cancer stem cells in paediatric leukaemia. Leukaemia is the most common form of cancer in children, and while the majority of children can be cured, those who relapse face a dire prognosis. It is widely believed that leukemic stem cells are responsible for relapse and this project will aim to unravel their underlying biology and identify new targets for therapeutic approaches to the disease.
Molecular hallmarks of androgen receptor targeting in prostate cancer. There is a critical need in oncology drug development for better biomarkers of response to prostate cancer therapies, clinically to assist with treatment decision making, and pre-clinically to facilitate translation of emerging agents into clinical practice. Using a unique explant culture model, this project will identify protein and lipid markers that can be used to accurately and reliably assess response to androgen recepto ....Molecular hallmarks of androgen receptor targeting in prostate cancer. There is a critical need in oncology drug development for better biomarkers of response to prostate cancer therapies, clinically to assist with treatment decision making, and pre-clinically to facilitate translation of emerging agents into clinical practice. Using a unique explant culture model, this project will identify protein and lipid markers that can be used to accurately and reliably assess response to androgen receptor (AR)-targeting therapies in human prostate tumours. The identification and functional assessment of these biomarkers will identify those that can be used as surrogate endpoints in clinical trials, facilitate earlier approval of investigational agents and lead to improved options for therapeutic management of prostate cancer.Read moreRead less
Understanding endocrine tumorigenesis - opportunities for new diagnostics and therapies. This project will generate new knowledge significant for improving cancer diagnosis and designing new therapies for cancer patients as we embrace the personalised medicine era. Specific focus is on endocrine tumours. This research has as its aim improved survival for people diagnosed with cancer.
Inherited determinants of cancer aetiology. Family history of cancer is a strong risk factor for many cancers. This project will aim to identify inherited factors influencing risk of developing cancer and those factors influencing the course of the disease and outcomes.
Caged lanthanides for use in photo-dynamic therapy and near infra-red imaging. The early detection and effective treatment of cancer are two critical factors which determine survivability. This project will provide improved drugs for photo-dynamic therapy and develop emissive probes for near infra-red imaging to allow better discrimination between healthy and diseased tissue and improve subsequent treatment.